School Assembly News Headlines For December 8, 2025 are AI/ML in Power Distribution and ECI Digitization; PM Modi to Initiate ...
Kite, a Gilead Company , presented a new analysis today demonstrating that second-line Yescarta® (axicabtagene ciloleucel) therapy offers consistent benefits in patients with relapsed/refractory large ...